Birzeit Pharmaceuticals Company (PEX:BPC)
3.600
-0.050 (-1.37%)
At close: Sep 3, 2025
PEX:BPC Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Cash & Equivalents | 1.72 | 3.07 | 3.11 | 3 | 1.14 | 2.55 | Upgrade |
Short-Term Investments | 0.5 | 0.5 | 0.5 | - | - | 1.5 | Upgrade |
Trading Asset Securities | 3.3 | 11.93 | 13.58 | 13.63 | 12.67 | 8.64 | Upgrade |
Cash & Short-Term Investments | 5.52 | 15.5 | 17.19 | 16.63 | 13.81 | 12.69 | Upgrade |
Cash Growth | -57.47% | -9.81% | 3.38% | 20.39% | 8.82% | -8.58% | Upgrade |
Accounts Receivable | 44.69 | 40.74 | 34.53 | 37.47 | 31.74 | 22.66 | Upgrade |
Other Receivables | 1.3 | 1.35 | 2.13 | - | 1.19 | 1.35 | Upgrade |
Receivables | 46 | 42.08 | 36.66 | 37.47 | 32.93 | 24.01 | Upgrade |
Inventory | 11.84 | 11.84 | 13.13 | 12.2 | 11.65 | 12.19 | Upgrade |
Prepaid Expenses | - | 0.27 | 0.14 | - | 0.11 | 0.11 | Upgrade |
Other Current Assets | 1.16 | 0.37 | 0.07 | 1.92 | 1.12 | 1.11 | Upgrade |
Total Current Assets | 64.52 | 70.06 | 67.19 | 68.22 | 59.62 | 50.11 | Upgrade |
Property, Plant & Equipment | 30.68 | 29.49 | 24.31 | 22.47 | 21.13 | 22.07 | Upgrade |
Long-Term Investments | 33.66 | 27.15 | 26.97 | 25.5 | 24.07 | 19.7 | Upgrade |
Long-Term Accounts Receivable | 0.7 | 0.65 | 0.06 | 0.05 | 0.45 | - | Upgrade |
Long-Term Deferred Tax Assets | 1.66 | 1.21 | 1.27 | 1.15 | 1.1 | 1.03 | Upgrade |
Other Long-Term Assets | 0.28 | 0.27 | 5.35 | 5.61 | 5.61 | 6.14 | Upgrade |
Total Assets | 131.5 | 128.82 | 125.15 | 123 | 111.98 | 99.06 | Upgrade |
Accounts Payable | 11.26 | 3.7 | 2.03 | - | 1.59 | 2.05 | Upgrade |
Accrued Expenses | - | 2.03 | 2.18 | - | 2.31 | 1.58 | Upgrade |
Current Portion of Long-Term Debt | - | - | - | 0.42 | 0.85 | 1.17 | Upgrade |
Other Current Liabilities | - | 7.11 | 3.97 | 7.15 | 2.42 | 2.52 | Upgrade |
Total Current Liabilities | 11.26 | 12.85 | 8.18 | 7.57 | 7.18 | 7.32 | Upgrade |
Long-Term Debt | - | - | - | 0.8 | 1.18 | 2.03 | Upgrade |
Total Liabilities | 22.64 | 23.94 | 20.12 | 19.49 | 19.18 | 19.33 | Upgrade |
Common Stock | 38.76 | 38.76 | 38.76 | 38.76 | 19.38 | 19 | Upgrade |
Retained Earnings | 69.68 | 63.76 | 60.52 | 58.14 | 70.39 | 61.54 | Upgrade |
Treasury Stock | -0.21 | -0.23 | -0.23 | -0.23 | -0.15 | -0.14 | Upgrade |
Comprehensive Income & Other | -0.05 | 1.9 | 5.27 | 5.91 | 2.24 | -1.53 | Upgrade |
Total Common Equity | 108.18 | 104.2 | 104.32 | 102.59 | 91.86 | 78.87 | Upgrade |
Minority Interest | 0.68 | 0.68 | 0.7 | 0.92 | 0.93 | 0.86 | Upgrade |
Shareholders' Equity | 108.86 | 104.88 | 105.02 | 103.51 | 92.79 | 79.73 | Upgrade |
Total Liabilities & Equity | 131.5 | 128.82 | 125.15 | 123 | 111.98 | 99.06 | Upgrade |
Total Debt | - | - | - | 1.22 | 2.03 | 3.2 | Upgrade |
Net Cash (Debt) | 5.52 | 15.5 | 17.19 | 15.41 | 11.78 | 9.49 | Upgrade |
Net Cash Growth | -57.47% | -9.81% | 11.53% | 30.87% | 24.09% | -0.26% | Upgrade |
Net Cash Per Share | 0.14 | 0.40 | 0.44 | 0.41 | 0.30 | 0.24 | Upgrade |
Filing Date Shares Outstanding | 38.34 | 38.76 | 38.71 | 35.24 | 38.76 | 38.76 | Upgrade |
Total Common Shares Outstanding | 38.34 | 38.76 | 38.71 | 35.24 | 38.76 | 38.76 | Upgrade |
Working Capital | 53.26 | 57.21 | 59.01 | 60.65 | 52.44 | 42.79 | Upgrade |
Book Value Per Share | 2.82 | 2.69 | 2.69 | 2.91 | 2.37 | 2.03 | Upgrade |
Tangible Book Value | 108.18 | 104.2 | 104.32 | 102.59 | 91.86 | 78.87 | Upgrade |
Tangible Book Value Per Share | 2.82 | 2.69 | 2.69 | 2.91 | 2.37 | 2.03 | Upgrade |
Land | - | 9.03 | 3.95 | - | 3.58 | 3.61 | Upgrade |
Buildings | - | 11.71 | 11.71 | - | 12.24 | 12.2 | Upgrade |
Machinery | - | 41.48 | 41.19 | - | 40.56 | 39.97 | Upgrade |
Construction In Progress | - | 7.26 | 6.04 | - | 0.44 | 0.35 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.